Guru Ownership Trend
Guru Analysis for Allogene Therapeutics, Inc. (ALLO)
Allogene Therapeutics, Inc. (ALLO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $7.38 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $1.81 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 79.2%. Conversely, Cliff Asness reduced exposure by 19.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Allogene Therapeutics, Inc. (ALLO)
Major holders include Renaissance Technologies (RenTech) ($7.98 M), Cliff Asness ($4.17 M), Murray Stahl ($34,894). According to the latest reported data, 3 tracked investment managers collectively hold approximately 5.86 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.81 M, with 1 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited ALLO. The total reported sell value was $1.71 M.
Yes, 0 managers opened new positions in ALLO, and 1 increased their existing holdings. The total reported buy value was $3.53 M.